番茄社区app

Infectious Disease >

RSV

News, opinions and meeting coverage in infectious disease.

A photo of a male physician preparing to vaccinate a pregnant woman.

Maternal RSV Vaccine Appears Safe, Real-World Study Finds

However, vaccine was associated with modest risk of maternal hypertensive disorders

A computer rendering of a respiratory syncytial virus.

ACIP Makes Changes to Adult RSV Vaccine Recommendations

Committee ditches shared decision-making, moves to risk-based approach

FDA APPROVED RSV prefusion F protein-based vaccine (Arexvy) over a microscope image of respiratory syncytial viruses.

FDA Expands Use of RSV Vaccine to Include More Adults

Arexvy now approved for people 50 years and older at increased risk of serious outcomes

A photo of the packaging and vials of the Arexvy respiratory syncytial virus vaccine.

Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says

But compared with mRNA COVID-19 vaccines, GBS was more common than expected

FDA APPROVED mRNA-1345 vaccine (mRESVIA) over a computer rendering of respiratory syncytial viruses.

FDA Approves First mRNA RSV Vaccine

Moderna vaccine indicated for people ages 60 and up

A photo of boxes of the Pfizer RSV vaccine (Abrysvo) and the GSK RSV vaccine (Arexvy).

Adult RSV Shots Given to More Than 30 Babies by Mistake

"Administration errors are preventable with proper education and training," say study authors

Photo of a doctor preparing a vaccine for a pregnant woman.

Most Expectant Moms Say They're Likely to Get Maternal RSV Vaccine

But one in five soon-to-be parents said they had never even heard of RSV, survey finds

A computer rendering of the cutaway of a respiratory syncytial virus

Cardiac Events Common in Older, Hospitalized RSV Patients

New RSV vaccines could reduce risk, researchers said

A computer rendered cutaway of a respiratory syncytial virus

Published Data Show Why GSK Bailed on Its Maternal RSV Vaccine

Solid efficacy for protecting infants from serious RSV marred by 37% higher risk of preterm birth

A photo of a box of Beyfortus over a scanning electron microscope image of RSV viruses.

CDC: Nirsevimab 90% Effective Against RSV Hospitalization in Infants

But effectiveness over a full RSV season expected to be lower, researchers caution

A computer rendering of a respiratory syncytial virus

CDC Monitoring Rare Neurologic Events After RSV Vaccination

Cases of Guillain-Barre syndrome in vaccinated older adults slightly higher than background rates

A computer rendering of antibodies binding to a respiratory syncytial virus

Nirsevimab Reduced Hospitalizations for Infants With RSV

Monoclonal antibody is highly effective, but in short supply

A photo of female nurses wearing protective gear tend to an infant with RSV in the pediatric ICU.

Pediatric RSV Led to Higher Hospitalization Rates Than Omicron or Flu

Study underscores urgent need to use preventive measures

A computer rendering of RSV viruses in the lungs.

Moderna's mRNA RSV Vaccine Effective in Older Adults

Whether it provides lasting protection remains to be seen

A computer rendering of respiratory syncytial virus particles

Prenatal RSV Infection Linked to Fetal Inflammation, Poorer Growth

Study may give force to recommendations for maternal RSV vaccination

AAP over a photo of Walter E. Washington Convention Center in Washington, DC.

Clinical Challenges: Navigating New RSV Protections for the Youngest Kids

Having options is worth the extra few minutes of conversation with families, physician says

A scanning electron microscope image of respiratory syncytial viruses

I Lost My Baby Brother to RSV, Others Don't Have To

Two new tools can prevent tens of thousands of hospitalizations and deaths

IDWeek over a photo of Boston Convention & Exhibition Center - Boston, MA.

RSV Vaccine Maintains Efficacy Across Two Seasons in Seniors

And second dose after 1 year appeared to add no extra protection

A photo of a senior man and woman in wheelchairs in a nursing home hallway.

Severity of RSV Hospitalizations Rivals COVID in Older Adults

Consider age, underlying medical conditions in RSV vaccine recs, researchers say

A computer rendering of RSV viruses.

A Framework to Communicate With Pregnant Patients About the RSV Vaccine

A values-based decision-making framework is key

A photo of a box of Abrysvo over a photo of a pregnant woman receiving a vaccination.

CDC Advisors Endorse Maternal RSV Vax to Protect Newborns

Vast majority of infants will not need monoclonal antibody if mom has received the vaccine

A photo of a male physician holding three vials of differently colored liquids and a syringe.

Can COVID, Flu, and RSV Shots Be Given at the Same Time?

Here's how experts are strategizing fall vaccines

A computer rendering of respiratory syncytial virus particles.

What to Know About New Tools to Fight RSV

Two vaccines and a monoclonal antibody aim to bring down the burden of RSV

FDA APPROVED RSV prefusion F protein vaccine (Abrysvo) over a photo of a male nurse preparing to vaccinate a pregnant woman.

RSV Vaccine Approved for Use in Pregnancy to Protect Infants

Prescribing info has warning about the potential risk for premature birth

A photo of the syringes and packaging of Beyfortus 100 mg/ml and 50 mg/ml.

CDC Advisors Back Therapeutic to Prevent RSV in Infants

Unanimous support for monoclonal antibody for infants and high-risk toddlers as well

FDA APPROVED nirsevimab (Beyfortus) over a computer rendering of respiratory syncytial viruses

New Drug Approved for Preventing RSV in Newborns, Tots

Nirsevimab indicated for all infants, and for kids up to 2 years at high risk

FDA ADCOMM nirsevimab over a computer rendered cutaway of an RSV virus.

Antibody for Infant RSV Prevention to Face FDA Panel

Nirsevimab shot also a possibility for some at-risk toddlers

FDA APPROVED Unadjuvanted, bivalent RSV prefusion F protein vaccine (Abrysvo) over a computer rendering of RSV viruses.

Second RSV Vaccine Lands Approval for Older Adults

Abrysvo approved for adults 60 and up

FDA VRBPAC RSVPreF3 vaccine (AREXVY) over a computer rendering of a cutaway RSV virus.

Second RSV Vaccine for Older Adults Gets Thumbs Up From FDA Advisors

VRBPAC unanimously endorses efficacy of GSK's protein fusion vaccine, not quite as sold on safety

FDA VRBPAC RSV prefusion F protein vaccine (ABRYSVO) over a computer rendered cutaway of the RSV virus.

FDA Panel Backs Pfizer's RSV Vaccine for Older Adults

But panelists raise multiple concerns over phase III trial data

A computer rendered cutaway view of the respiratory syncytial virus

FDA Flags Potential Guillain-Barre Risk With RSV Vaccine Candidates

Both vaccines demonstrated high efficacy against symptomatic illness in large phase III trials

A computer rendering of respiratory syncytial viruses

RSV Vaccine Succeeds in Phase III Trial of Older Adults

Here's what it could mean in practice

A computer rendering of a monoclonal antibody.

Monoclonal Antibodies Linked to Reduced RSV Burden in Young Kids

Meta-analysis of 14 RCTs showed significant reductions in infection, hospitalization

A photo of a nurse wearing a surgical mask while tending to an infant suffering from respiratory syncytial virus.

Our Pediatric 'Immunity Debt' Is Really an 'RSV Debt'

The virus is now collecting what it is owed

IDWeek over a photo of the Walter E. Washington Convention Center in Washington, DC

Vaccine Candidates for RSV Ward Off Severe Illness in Older Adults

Trials show upwards of 85% protection against more severe cases of respiratory syncytial virus

A scanning electron micrograph of human respiratory syncytial virus

Novel Drug Shows Promise for Respiratory Syncytial Virus

Challenge trial involving healthy adults showed superiority to placebo at multiple doses

A computer rendering of the respiratory syncytial virus

What Caused RSV to Roar Back During COVID?

Multinational study pinpoints the most important drivers of the seasonal illness

2021 YEAR IN REVIEW respiratory syncytial virus over a computer rendering of the virus.

Year in Review: Respiratory Syncytial Virus

Vaccine development for older adults continued apace, virus roared back in kids

IDWeek over a computer rendering of the COVID-19 virus.

Vaccine Could Be Shot in the Arm Against RSV in Older Adults

CYPRESS proof-of-concept study shows high efficacy against acute illness

FDA Advisers Turn Down New RSV Drug

WASHINGTON -- An FDA advisory committee recommended Wednesday that the agency not approve the investigational drug motavizumab to treat respiratory infections, deciding that it didn't offer any advantages over the drug already on the market, and that it may be more dangerous.